Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug
05 mars 2007 10h55 HE
|
Samaritan Pharmaceuticals, Inc.
Enters Service Agreement With Advinus Therapeutics, India to Validate
Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol
Strategy is to Bolster Caprospinol Alzheimer's Data...
Samaritan Pharma Completes Acquisition of Metastatin Pharmaceuticals
01 mars 2007 09h56 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, March 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announced today that the company has closed its acquisition of...
Shire plc Signs Marketing Agreement With Samaritan Pharma
26 févr. 2007 10h24 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Feb. 26, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has signed a marketing and distribution agreement,...
Samaritan Pharma Files Patent to Protect SP-04 as Bioterrorism Nerve Gas Antidote
22 févr. 2007 09h53 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Feb. 22, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has filed a patent application to protect SP-04 as a...
Samaritan Pharma Aims At SP-6300 as New Innovative Treatment for Cushing's Syndrome
06 févr. 2007 12h05 HE
|
Samaritan Pharmaceuticals, Inc.
Files New Patent Application for SP-6300 Making Use
of SP-01A's Phase II Study Data
Drug SP-01A (HIV), SP-6300 (Cushing's) Demonstrates a Statistically
...
Samaritan Pharma Requests Hearing Before AMEX's Listing Qualifications Panel to Appeal Non-Acceptance of Company's Compliance Plan
02 févr. 2007 18h01 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Feb. 2, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announces it has requested a hearing before the AMEX's listing qualifications...
Samaritan Pharma's SP-10 Hip On Hep C
25 janv. 2007 12h33 HE
|
Samaritan Pharmaceuticals, Inc.
* National Institutes of Allergy and Infectious Diseases (NIAID)
Finds Significant Antiviral Activity With Entry Inhibitor SP-10
for Hepatitis C Virus (HCV)
* "Oral" Antiviral Entry...
Breath of Life Product In-Licensed to Samaritan Pharma
22 janv. 2007 10h54 HE
|
Samaritan Pharmaceuticals, Inc.
* ONY's Neonatal U.S. Approved Drug Infasurf to Treat Respiratory
Distress Syndrome in Premature Infants In-Licensed
* Marketing and Sales Rights Granted for Turkey, Serbia, Bosnia,
...
Samaritan Pharma In-Licenses Rights to Promote and Sell Six of Molteni's Prescription Drugs for Pain, Drug Addiction and Anesthesia in Greece and Cyprus
16 janv. 2007 10h33 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Jan. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that it has signed an exclusive license with Molteni...
FDA Grants IND to Samaritan's Novel Plaque Clearing Alzheimer's Drug and Requests Additional Information Be Provided Before Starting Its Proposed Phase I Trial
07 déc. 2006 10h15 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 7, 2006 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced that the U.S. Food and Drug Administration (FDA) has completed its...